Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Gains from Sales and Divestitures (2016 - 2025)

Bio-Techne has reported Gains from Sales and Divestitures over the past 10 years, most recently at $134000.0 for Q2 2025.

  • For Q2 2025, Gains from Sales and Divestitures rose 346.67% year-over-year to $134000.0; the TTM value through Jun 2025 reached $134000.0, up 346.67%, while the annual FY2025 figure was $134000.0, 346.67% up from the prior year.
  • Gains from Sales and Divestitures for Q2 2025 was $134000.0 at Bio-Techne, up from $30000.0 in the prior quarter.
  • Over five years, Gains from Sales and Divestitures peaked at $206000.0 in Q2 2021 and troughed at $30000.0 in Q2 2024.
  • A 5-year average of $127600.0 and a median of $134000.0 in 2025 define the central range for Gains from Sales and Divestitures.
  • Biggest five-year swings in Gains from Sales and Divestitures: plummeted 75.61% in 2024 and later surged 346.67% in 2025.
  • Year by year, Gains from Sales and Divestitures stood at $206000.0 in 2021, then decreased by 29.61% to $145000.0 in 2022, then dropped by 15.17% to $123000.0 in 2023, then plummeted by 75.61% to $30000.0 in 2024, then surged by 346.67% to $134000.0 in 2025.
  • Business Quant data shows Gains from Sales and Divestitures for TECH at $134000.0 in Q2 2025, $30000.0 in Q2 2024, and $123000.0 in Q2 2023.